NYSE ARCA | ETF
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index.
The index seeks to track the performance of the common stock ofU. S. exchange-listed biotechnology companies with at least one drug therapy approved by theU. S.
Food and Drug Administration (FDA) for marketing.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| DCPH | Deciphera Pharmaceuticals LLC | Healthcare | Drug Manufacturers - Specialty & Generic | 3.02% |
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 2.51% |
| SAGE | Sage Therapeutic | Healthcare | Biotechnology | 2.07% |
| HRMY | Harmony Biosciences Holdings | Healthcare | Biotechnology | 2.03% |
| BBIO | BridgeBio Pharma Inc | Healthcare | Biotechnology | 2.03% |
| BPMC | Blueprint Medicines Corp | Healthcare | Biotechnology | 1.97% |
| BGNE | BeiGene Ltd | Healthcare | Biotechnology | 1.93% |
| HALO | Halozyme Therapeutics Inc | Healthcare | Biotechnology | 1.90% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.88% |
| MIRM | Mirum Pharmaceuticals Inc | Healthcare | Biotechnology | 1.84% |
| EXEL | Exelixis Inc | Healthcare | Biotechnology | 1.71% |
| IRWD | Ironwood Pharmaceuticals Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.71% |
| TVTX | Travere Therapeutics Inc | Healthcare | Biotechnology | 1.70% |
| ACAD | ACADIA Pharmaceuticals Inc | Healthcare | Biotechnology | 1.69% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 1.69% |
| INSM | Insmed Inc | Healthcare | Biotechnology | 1.67% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 1.67% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 1.66% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 1.65% |
| UTHR | United Therapeutics Corporation | Healthcare | Biotechnology | 1.65% |